ArticleJournal of neuro-oncology2016
Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.
Shamik Chakraborty et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
56 papers cite it
this paperpooled itcites it